PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'1Department of Radiation Oncology.\', \'2Department of Medicine.\', \'3Department of Biostatistics.\', \'4Institute of Cancer Research, Blood Cell Development and Function.\', \'5Department of Hematology/Oncology.\', \'6Department of Surgical Oncology.\', \'7Department of Clinical Genetics, and.\', \'8Institute of Cancer Research, Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and.\', \'9Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.6004/jnccn.2021.7113jnccn21447
?:hasPublicationType
?:journal
  • Journal of the National Comprehensive Cancer Network : JNCCN
is ?:pmid of
?:pmid
?:pmid
  • 35130494
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.592
?:rankingScore_hIndex
  • 78
is ?:relation_isRelatedTo_publication of
?:title
  • Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all